Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Salgia

Showing results (141-150 of 528) with videos related to

Pageof 53
Sort By:
JCO Oncology Practice|March 10, 2021
Improving Care for Patients With Stage III or IV NSCLC: Learnings for Multidisciplinary Teams From the ACCC National Quality SurveyRavi Salgia, Leigh M Boehmer, Catherine Celestin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Unusual problems in breast cancer and a rare lung cancer case. Case 4. Primary lymphoepithelioma-like carcinoma of the lungHanna Y Irie, Michael T Jaklitsch, Kitt Shaffer, et al.
Cureus|March 31, 2016
Concurrent EGFR Mutation and ALK Translocation in Non-Small Cell Lung CancerRandy F Sweis, Sachdev Thomas, Bruce Bank, et al.
Cancers|November 27, 2024
Artificial Intelligence-Driven Computational Approaches in the Development of Anticancer DrugsPankaj Garg, Gargi Singhal, Prakash Kulkarni, et al.
Molecular Cancer Research : MCR|November 6, 2019
USP22 Interacts with PALB2 and Promotes Chemotherapy Resistance via Homologous Recombination of DNA Double-Strand BreaksIsaac K Nardi, Jeremy M Stark, Adrien Larsen, et al.
Cancer Medicine|December 7, 2021
Infectious complications of immune checkpoint inhibitors in solid organ malignanciesJustine Abella Ross, Kellie Komoda, Sumanta Pal, et al.
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|October 30, 2004
Modulation of c-Kit/SCF pathway leads to alterations in topoisomerase-I activity in small cell lung cancerGautam Maulik, Ajit Bharti, Ehsan Khan, et al.
Bioinformatics (Oxford, England)|January 8, 2019
The DNA walk and its demonstration of deterministic chaos-relevance to genomic alterations in lung cancerBlake Hewelt, Haiqing Li, Mohit Kumar Jolly, et al.
Journal of Neurology Research|March 19, 2013
Temozolomide and/or Erlotinib in the Treatment of Lung Cancer Patients With Progressive Central Nervous System MetastasesRimas V Lukas, Martin Kelly Nicholas, Victoria Villaflor, et al.
Cancer Biology & Therapy|March 15, 2008
C. elegans as a model organism for in vivo screening in cancer: effects of human c-Met in lung cancer affect C. elegans vulva phenotypesShahid S Siddiqui, Sivakumar Loganathan, Soundararajan Krishnaswamy, et al.
Pageof 53

Showing results (141-150 of 528) with videos related to

Sort By:
Pageof 53
JCO Oncology Practice|March 10, 2021
Improving Care for Patients With Stage III or IV NSCLC: Learnings for Multidisciplinary Teams From the ACCC National Quality SurveyRavi Salgia, Leigh M Boehmer, Catherine Celestin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Unusual problems in breast cancer and a rare lung cancer case. Case 4. Primary lymphoepithelioma-like carcinoma of the lungHanna Y Irie, Michael T Jaklitsch, Kitt Shaffer, et al.
Cureus|March 31, 2016
Concurrent EGFR Mutation and ALK Translocation in Non-Small Cell Lung CancerRandy F Sweis, Sachdev Thomas, Bruce Bank, et al.
Cancers|November 27, 2024
Artificial Intelligence-Driven Computational Approaches in the Development of Anticancer DrugsPankaj Garg, Gargi Singhal, Prakash Kulkarni, et al.
Molecular Cancer Research : MCR|November 6, 2019
USP22 Interacts with PALB2 and Promotes Chemotherapy Resistance via Homologous Recombination of DNA Double-Strand BreaksIsaac K Nardi, Jeremy M Stark, Adrien Larsen, et al.
Cancer Medicine|December 7, 2021
Infectious complications of immune checkpoint inhibitors in solid organ malignanciesJustine Abella Ross, Kellie Komoda, Sumanta Pal, et al.
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|October 30, 2004
Modulation of c-Kit/SCF pathway leads to alterations in topoisomerase-I activity in small cell lung cancerGautam Maulik, Ajit Bharti, Ehsan Khan, et al.
Bioinformatics (Oxford, England)|January 8, 2019
The DNA walk and its demonstration of deterministic chaos-relevance to genomic alterations in lung cancerBlake Hewelt, Haiqing Li, Mohit Kumar Jolly, et al.
Journal of Neurology Research|March 19, 2013
Temozolomide and/or Erlotinib in the Treatment of Lung Cancer Patients With Progressive Central Nervous System MetastasesRimas V Lukas, Martin Kelly Nicholas, Victoria Villaflor, et al.
Cancer Biology & Therapy|March 15, 2008
C. elegans as a model organism for in vivo screening in cancer: effects of human c-Met in lung cancer affect C. elegans vulva phenotypesShahid S Siddiqui, Sivakumar Loganathan, Soundararajan Krishnaswamy, et al.
Pageof 53